$Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: The Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial$

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: The Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

10.1161/CIRCHEARTFAILURE.112.970061

Saved in:

Bibliographic Details
Main Authors:	Lam, C.S.P., Carson, P.E., Anand, I.S., Rector, T.S., Kuskowski, M., Komajda, M., McKelvie, R.S., McMurray, J.J., Zile, M.R., Massie, B.M., Kitzman, D.W.
Other Authors:	MEDICINE
Format:	Article
Published:	2016
Subjects:	Aging Heart failure Preserved left ventricular function Prognosis Sex
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/126853
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Obesity and heart failure with preserved ejection fraction
by: Wattana Leowattana
Published: (2020)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
by: Bai, B., et al.
Published: (2021)

Heart failure with preserved ejection fraction in women: The dutch queen of hearts program
by: den Ruijter H, et al.
Published: (2016)

Endothelial dysfunction: A pathophysiologic factor in heart failure with preserved ejection fraction
by: Lam, C.S.P., et al.
Published: (2016)

Cornell product is an ECG marker of heart failure with preserved ejection fraction
by: Tan, Eugene SJ, et al.
Published: (2023)

Thymosin beta-4 is elevated in women with heart failure with preserved ejection fraction
by: Drum C.L., et al.
Published: (2020)

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction. A Community-Based Study
by: Lam, C.S.P., et al.
Published: (2015)

Large animal models of heart failure: Reduced vs. preserved ejection fraction
by: Charles, C.J., et al.
Published: (2021)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Sweeney, M., et al.
Published: (2021)

BIOMECHANICS OF HEART FAILURE WITH PRESERVED EJECTION
by: ZHENG YU
Published: (2023)

Circulating neuregulin1-? in heart failure with preserved and reduced left ventricular ejection fraction
by: Hage, C., et al.
Published: (2021)

The Effectiveness of Non-Pharmacological Interventions in Patients with Heart Failure with Preserved Ejection Fraction
by: AMANDA TAN LI YEE
Published: (2021)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
by: Chen, Y.-T., et al.
Published: (2021)

Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction
by: Yap, J., et al.
Published: (2021)

Patient-reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence
by: Huang, W., et al.
Published: (2021)

A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics
by: Charles, C.J., et al.
Published: (2021)

Pharmacological treatments for heart failure with preserved ejection fraction—a systematic review and indirect comparison
by: Kwadwo Osei Bonsu, et al.
Published: (2018)

Pharmacological treatments for heart failure with preserved ejection fraction—a systematic review and indirect comparison
by: Kwadwo Osei Bonsu, et al.
Published: (2018)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
by: Tay, Wan Ting, et al.
Published: (2023)

Quantification of biventricular strains in heart failure with preserved ejection fraction patient using hyperelastic warping method
by: Zou, H, et al.
Published: (2020)

Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota
by: Lam, C.S.P., et al.
Published: (2015)

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry
by: MacDonald, M.R., et al.
Published: (2021)

Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction
by: Thammarak Songsangjinda, et al.
Published: (2022)

Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction
by: Songsangjinda T.
Published: (2023)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
by: Patel, Ravi B., et al.
Published: (2022)

Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand
by: Kittayaporn Chairat, et al.
Published: (2020)

Material property alterations for phenotypes of heart failure with preserved ejection fraction: A numerical study of subject-specific porcine models
by: Weissmann, J, et al.
Published: (2023)

Association of Prior Left Ventricular Ejection Fraction with Clinical Outcomes in Patients with Heart Failure with Midrange Ejection Fraction
by: Alison Brann, et al.
Published: (2020)

Myocardial contractile dysfunction associated with increased 3-month and 1-year mortality in hospitalized patients with heart failure and preserved ejection fraction
by: Zhong, L., et al.
Published: (2016)

The Singapore heart failure outcomes and phenotypes (SHOP) study and prospective evaluation of outcome in patients with heart failure with preserved left ventricular ejection fraction (PEOPLE) study: Rationale and design
by: Santhanakrishnan, Rajalakshmi, et al.
Published: (2013)

Relationship between Serum Dehydroepiandrosterone Levels and Heart Ejection Fraction in Heart Failure Patients
by: Rima Hayyu Chrisnanda, -, et al.

Effect of a comprehensive heart failure treatment program on left ventricular ejection fraction and six-minute walk distance in heart failure patients with reduced ejection fraction at Lampang Hospital
by: Boonyapiphat T, et al.
Published: (2020)

Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction
by: Rungroj Krittayaphong, et al.
Published: (2022)

Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction
by: Krittayaphong R.
Published: (2023)

Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload
by: Ye L., et al.
Published: (2020)

Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
by: Rungroj Krittayaphong, et al.
Published: (2020)

Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
by: Rungroj Krittayaphong, et al.
Published: (2020)

Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction
by: Satit Janwanishstaporn, et al.
Published: (2022)

Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction
by: Janwanishstaporn S.
Published: (2023)

Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis
by: Treewaree S.
Published: (2023)